The use of indwelling totally implantable central venous catheters (portacath) became a commonplace in anticancer treatment, and inspite of the great value of their use, four types of possible complications were defined: mechanical, thrombotic, mal-functioning and infections. 1 By far, the most two serious are infections and deep venous thrombosis that mandate an energetic wise decision. While the mere evidence of infection spells immediate catheter removal, the situation is totally different with deep venous thrombosis and represents a matter of debate in its management.Thrombosis is a common complication in patients with malignant disease, resulting from tumor liberation of pro-coagulants with subsequent activation of intravascular coagulation factors. Cancer therapies as operations, chemotherapy, and the use of portacath further heighten the risk of thrombosis. 2